Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure
about
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wastingCardiac cachexia: hic et nuncFrailty in Advanced Heart Failure: A Consequence of Aging or a Separate Entity?Inflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical ExerciseThe central role of hypothalamic inflammation in the acute illness response and cachexiaThe role of metabolic syndrome in heart failureTreatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animalsModels of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.Despite Inflammation, Supplemented Essential Amino Acids May Improve Circulating Levels of Albumin and Haemoglobin in Patients after Hip FracturesRole of exercise training on autonomic changes and inflammatory profile induced by myocardial infarctionGenetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failureThe effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.Hypothalamic mechanisms in cachexia.Defects in insulin action in chronic heart failure.Immune and neurohormonal pathways in chronic heart failure.Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activationInfluence of progressive renal dysfunction in chronic heart failure.Down-regulation of MyoD gene expression in rat diaphragm muscle with heart failure.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart.Sarcopenia: clinical evaluation, biological markers and other evaluation tools.Adipose triglyceride lipase and hormone-sensitive lipase are involved in fat loss in JunB-deficient mice.Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circleTarget population for clinical trials on sarcopenia.Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure.Fish oils--adjuvant therapy in chronic heart failure?Cardiac cachexia.A meta-analysis of proinflammatory cytokines in chronic heart failure.An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease.Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.Bone loss in Crohn's disease: exercise as a potential countermeasure.A Novel Analytic Technique to Measure Associations Between Circulating Biomarkers and Physical Performance Across the Adult Life Span.Cardiac cachexia at a glance.Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study.Molecular inflammation: underpinnings of aging and age-related diseases.Muscle size explains low passive skeletal muscle force in heart failure patients.Obesity and diabetes as accelerators of functional decline: can lifestyle interventions maintain functional status in high risk older adults?The role of exercise on L-arginine nitric oxide pathway in chronic heart failure.Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.Skeletal muscle abnormalities in chronic heart failure.
P2860
Q24609841-7A0A4463-5F34-4F8B-A374-201231A7CE59Q26744140-664C0358-99B1-4CED-81C0-87D9821E2467Q26798517-C263CB3A-AA71-4EE0-8CD4-6F6F3A58942CQ28076878-5B46CE8A-CA3C-4CF4-AB39-758784B0630EQ28080648-E4B59DBF-FE7A-45A3-AA32-F34580315759Q28085668-51321C02-3146-4FAB-AA36-3A94925139D8Q28570699-04C75F50-7B14-44A7-970C-10F04383FF49Q33349016-5F7F7330-F23A-42D1-B706-1EF5F311DDC4Q33852230-CBDDBAF9-65DD-460A-A05C-ED7617A53E45Q33876247-2E6A9BCF-0B21-4E3D-A912-F73A11E3F3FFQ33919515-FC07CD7B-E20C-4DAD-83EC-3FD53E93533FQ33948639-92A43C77-4BDF-42AB-BC90-F9AC6EA0F9A1Q34081332-7C90F3F9-C6C2-4006-87B4-EF4192949A4BQ34166305-7068DB2D-70F2-478B-B91C-664C0530A685Q34513186-19F78A07-D396-4416-B830-B078D0C18472Q34546722-9291648F-66BE-48EA-87F4-CCB2A2627591Q34604651-FCE0130B-125D-4542-A477-9CF0AC1FC2A0Q34656253-BC5E4418-6804-4C20-8B7F-F43F3165BF51Q34681621-4A8E3007-A47F-4AF1-8447-4FEA207EAD2BQ35026157-A6330132-65D6-4EA6-B0D0-FE23643E6984Q35034119-7C3DF35E-B689-4E72-A82B-6FCF4791C6CBQ35154661-10957F1A-D4F8-4483-A204-E0329ECAE695Q35223968-755105D7-DAC2-4013-83F4-D5C22AF36817Q35258802-DD377FA7-E5BA-4D09-8DFC-1FD125E68A31Q35583476-B92B204B-6F63-4C6F-A44E-4B1C6440A557Q35855345-B0476466-DF90-448E-8925-7B522657EB5BQ35932382-399AFA56-6E19-48AE-AB5A-ADEE073F39A9Q36057476-35048D0E-C6CF-4CE0-973C-598E034323BDQ36146980-FCAB048A-A273-4400-8E5E-52AA6BFC39CCQ36203181-B6BDC464-694B-4788-A0E7-368C5337E5E2Q36321697-2ADDA576-BF02-4419-9EEA-B05334143BB3Q36492364-CCFC92E8-D6A2-4559-9F31-A275352A02F8Q36836579-AAD33825-E5C0-4874-888D-556567CB8A64Q37156489-296F38C3-2FA0-4E75-AA30-D9D5B4BD7882Q37197324-59BCD2F3-7EED-443D-BB33-C5C8DE4B3F5DQ37267142-BA5D984F-68C2-4288-AF02-0D8FF4D881EAQ37279678-8D4F3E00-50A8-4BFF-9981-ADEAC00857B8Q37416187-524242F9-B5AC-4865-B840-D61D977334B7Q37827023-FAB7BE0E-74A9-45D7-A536-884312EDE7CBQ37994970-EF1E206A-B6B6-420A-88FC-8242836AFC27
P2860
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure
description
article
@en
im Mai 1999 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1999
@uk
name
Cytokines and neurohormones re ...... drome of chronic heart failure
@en
Cytokines and neurohormones re ...... drome of chronic heart failure
@nl
type
label
Cytokines and neurohormones re ...... drome of chronic heart failure
@en
Cytokines and neurohormones re ...... drome of chronic heart failure
@nl
prefLabel
Cytokines and neurohormones re ...... drome of chronic heart failure
@en
Cytokines and neurohormones re ...... drome of chronic heart failure
@nl
P2093
P356
P1476
Cytokines and neurohormones re ...... drome of chronic heart failure
@en
P2093
Hellewell PG
Poole-Wilson PA
Rauchhaus M
Teixeira MM
P304
P356
10.1053/EUHJ.1998.1446
P577
1999-05-01T00:00:00Z